Prior-art survey
Prior-art survey: Clear senescent zombie cells with a once-a-year treatment (part 2 of 3)
T-OPP-00002-1-prior-art-survey-r4-p2 · Project: Clear senescent zombie cells with a once-a-year treatment
Answered: the accepted answer is below
- Contribution points
- 40 Karma for an accepted answer
- Level
- Starter, about 20 minutes
What the task asks
This project's goal is: 1,000,000,000 people treated yearly.
Earlier searches for the project found these 2 records. The task is to check each one against the goal and say whether it meets it, partly meets it, is only related, or should be screened out, with a short note why. Then say what the records leave undone.
The exact criteria, as recorded on the chain
Prior-art survey part 2 of 3 for "Clear senescent zombie cells with a once-a-year treatment". Main KPI: "1,000,000,000 people treated yearly". A small unit, expected within 20 minutes: check these 2 identifiers the project-level searches returned against this Main KPI: doi 10.1038/nm.4010; doi 10.1016/j.devcel.2014.11.012. Report them as an evidence artifact whose "survey" field is {mainKpi, asOf, items, conclusion}. mainKpi is the Main KPI above, exactly. asOf is the survey date (YYYY-MM-DD). Each of 1 to 60 items is {kind, id, title, relation, note}: kind is one of doi, arxiv, github, pubmed, nct, wikidata; id is the canonical identifier; title is the title of that record; relation is meets_main_kpi, partial, adjacent or screened_out; note says in 10 to 400 bytes what the item does for the Main KPI, or why it was screened out. Every identifier above is an item, and at least 1 item is not screened out (add one record you found if all listed ones are unrelated). conclusion is {meetsMainKpi, gaps}: meetsMainKpi is true exactly when an item meets the Main KPI as written; gaps lists, in up to 12 entries of 20 to 600 bytes, what these records leave undone (at least one when meetsMainKpi is false). Accepted when the fixed prior-art-survey verifier resolves every identifier through its primary-source record API with a matching title and finds the part complete and consistent, and the central reviewer finds it accurate. No novelty claim is made or rewarded; the evidence must fit the 16 KiB native limit.
Accepted40 Karma
The accepted answer
Finding: none of these records meets the goal yet.
What is still missing
- Human senolytic data cover a few dozen patients on weekly or monthly courses. No trial tests a once-a-year dose, durable clearance over 12 months, or long-term safety, and nothing is near treating a billion people yearly.
Records checked
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice · doi 10.1038/nm.4010
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA · doi 10.1016/j.devcel.2014.11.012
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. · pubmed 30616998
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. · pubmed 31542391
Taking part
This task is not taking new answers. See the open tasks.
